Ameritas Investment Partners, Inc. Tyme Technologies, Inc. Transaction History

Ameritas Investment Partners, Inc.

  • $2.84 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021
SELL
$1.14 - $1.87 $6,976 - $11,444
-6,120 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$2.01 - $4.21 $5,024 - $10,525
2,500 Added 69.06%
6,120 $23,000
Q2 2018

Aug 13, 2018
BUY
$2.05 - $4.09 $7,420 - $14,805
3,620 New
3,620 $11,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email